EmCyte Corporation

EmCyte Corporation is a leader in regenerative medicine, specializing in autologous biologic preparation systems and technologies. Based in Fort Myers, Florida, the company manufactures advanced centrifugal platforms and processing equipment for creating customizable platelet-rich plasma (PRP), bone marrow concentrate (BMC), adipose concentrate, and protein concentrate formulations. EmCyte's PURE® SupraPhysiologic Concentrating Systems and Sapphire™ Centrifuge enable physicians to tailor biologic treatments for orthopedic, soft tissue, and regenerative therapy applications. The company also provides clinical training, ultrasound injection guidance, and scientific research support through affiliated entities (Gulf Coast Biologic Training and Biofyl Scientific Research). All manufacturing is conducted in the USA using advanced cleanroom environments and precision techniques, serving over 1,000 providers and supporting treatment for nearly 1.9 million patients.